RAC 5.59% $1.70 race oncology ltd

Pillar 1 - FTO (new thread), page-2317

  1. 441 Posts.
    lightbulb Created with Sketch. 674
    Yet again, Zantrene (CS1/Bisantrene)'s effectiveness against upregulated FTO expression has been independently tested and validated.

    The possibility of early buyout is very real - whether that's good or bad is really up to you.

    Let's hope we're also close to some price-sensitive announcements and formal partnerships that may correct and rerate the SP to safeguard against a low buyout figure.


 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.